I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 8 studies | 23% ± 6% | |
| naive B cell | 6 studies | 19% ± 2% | |
| oligodendrocyte | 6 studies | 25% ± 5% | |
| B cell | 5 studies | 21% ± 4% | |
| adipocyte | 5 studies | 20% ± 4% | |
| fibroblast | 5 studies | 20% ± 3% | |
| GABAergic neuron | 5 studies | 30% ± 12% | |
| natural killer cell | 4 studies | 17% ± 1% | |
| CD16-negative, CD56-bright natural killer cell, human | 4 studies | 17% ± 1% | |
| CD4-positive, alpha-beta T cell | 4 studies | 19% ± 2% | |
| retinal bipolar neuron | 4 studies | 25% ± 10% | |
| microglial cell | 4 studies | 21% ± 2% | |
| epithelial cell | 4 studies | 30% ± 5% | |
| retinal rod cell | 4 studies | 18% ± 3% | |
| astrocyte | 4 studies | 33% ± 7% | |
| glutamatergic neuron | 4 studies | 50% ± 23% | |
| oligodendrocyte precursor cell | 4 studies | 32% ± 8% | |
| macrophage | 4 studies | 18% ± 3% | |
| CD16-positive, CD56-dim natural killer cell, human | 3 studies | 18% ± 1% | |
| ciliated cell | 3 studies | 22% ± 4% | |
| CD8-positive, alpha-beta memory T cell | 3 studies | 16% ± 0% | |
| regulatory T cell | 3 studies | 18% ± 2% | |
| interneuron | 3 studies | 33% ± 13% | |
| neuron | 3 studies | 22% ± 7% |
